Members of the Mercury Medical Technologies team have deep expertise in the commercialization of medical technologies, including strategy and planning, engineering, funding, manufacturing and marketing. This team also understands the regulatory pathways and reimbursement landscapes that human health-focused start-ups have to navigate.

Mercury Medical Technologies works closely with other members of the regional and statewide bioscience ecosystem, including the Washington State Department of Commerce, Washington Biotechnology and Biomedical Association, the University of Washington (Bothell and Seattle campuses including the Center for Commercialization C4C), local medical centers and more. The Mercury Medical Technologies team has also invested in building relationships with life sciences funders, including various angel investment groups, and specialist venture capital firms both inside and outside Washington.